1,948 results on '"Izopet, Jacques"'
Search Results
2. A simple, sensitive and quantitative FACS-based test for SARS-CoV-2 serology in humans and animals
3. Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
4. Evaluation of an automated platform for the detection of HEV RNA in plasma and stool
5. HIV-1 genotypic resistance testing using single molecule real-time sequencing
6. Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination
7. Intact proviruses are enriched in the colon and associated with PD-1+TIGIT− mucosal CD4+ T cells of people with HIV-1 on antiretroviral therapy
8. Impact of respiratory pathogens detection by a rapid multiplex polymerase chain reaction assay on the management of community-acquired pneumonia for children at the paediatric emergency department. A randomized controlled trial, the OPTIPAC study
9. Evaluation of two anti-SARS-CoV-2 antibody immunoassays for monitoring patients on pre-exposure prophylaxis
10. The pressing need for a global HEV vaccine
11. Contributors
12. Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosus
13. Characterization of virus‒host recombinant variants of the hepatitis E virus
14. Increased Prevalence of Antibodies to Hepatitis E Virus in Patients with Neurocysticercosis
15. Effect of steroid pulses in severe BK virus allograft nephropathy with extensive interstitial inflammation
16. Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen.
17. Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response
18. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.
19. Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study
20. Failure of favipiravir to treat chronic norovirus infection in a kidney‐transplant patient
21. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation
22. Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
23. Human papillomavirus testing using HPV APTIMA® assay and an external cellularity control in self‐collected samples
24. Molecular evolution of omicron variant in immunocompromised individuals with chronic SARS-CoV-2 infection
25. Influence of age on the spread of SARS-CoV-2 variant B.1.1.7
26. Risk for Hepatitis E Virus Transmission by Solvent/ Detergent--Treated Plasma
27. Th22 cells are efficiently recruited in the gut by CCL28 as an alternative to CCL20 but do not compensate for the loss of Th17 cells in treated HIV-1-infected individuals
28. HPV genotyping in clinical samples using long‐read single‐molecule real‐time sequencing.
29. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics
30. Performance of the Xpert HBV Viral Load assay versus the Aptima Quant assay for quantifying hepatitis B virus DNA
31. L15-1 Virus de l[StQuote]hépatite E : perspectives et implications cliniques
32. CO8-6 Généralisation du DGV du VHE à l[StQuote]EFS : données d[StQuote]hémovigilance
33. Which Hepatitis E virus to worry about in our transplant patients.
34. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies
35. Hepatitis E virus infections in Europe
36. Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients
37. Management of Hepatitis A and E Virus Infection
38. HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway
39. Performance characteristics of the VIDAS® ANTI-HEV IgM and IgG assays
40. Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients
41. Performance of a commercial assay for detecting and quantifying HEV RNA in faeces
42. Detection of Zika, dengue and chikungunya viruses using single-reaction multiplex real-time RT-PCR
43. HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms.
44. Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19.
45. SARS-CoV-2 Co-Infections and Recombinations Identified by Long-Read Single-Molecule Real-Time Sequencing
46. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen
47. A fully automated system using transcription-mediated amplification for the molecular diagnosis of hepatitis E virus in human blood and faeces
48. A European multicenter study on the analytical performance of the VERIS HBV assay
49. Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays
50. Multirecombinant Enterovirus A71 Subgenogroup C1 Isolates Associated with Neurologic Disease, France, 2016-2017
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.